Galenea, Eisai to develop synaptic modulators

Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) and Galenea Corp. (Cambridge, Mass.) partnered to discover and develop synaptic modulators to treat neurodegenerative diseases. The partners will use Galenea's ...